C. Tridente, M. Casiello, G. Foia, M. Petrosino, B. Speranza, A. Tridente, G. Muscettola - Vol. 11, March 2005, Issue 1
Testo Immagini Bibliografia Summary Indice
Antipsicotici, variazioni ponderali ed
aderenza al trattamento in un campione di pazienti ambulatoriali
Antipsychotic drugs, weight changes and drug adherence in an outpatient
sample
1 Angermeyer MC, Matschinger H. Attitude of family to neuroleptis [in German]. Psychiatr Prax 1999.
2 McIntyre RS, McCann SM, Kennedy SH. Antipsychotic Metabolic Effects: Weight Gain, Diabetes Mellitus, and Lipid Abnormalities. Can J Psychiatry, April 2001.
3 National Institute of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults -the evidence report. Obes Res 1998.
4 Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis. Am J Psychiatry November 1999.
5 Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999.
6 McEvoy JP, Freudenreich O, Wislon WH. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 1999.
7 Theisen FM, Linden A, Konig IR, Martin M, Remschmidt H, Hebebrand J. Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 2003.
8 Meyer JM. Awareness of Obesity and Weight Issues Among Chronically Mentally Inpatients: A Pilot Study. Ann Clin Psychiatry 2002.
9 Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic non compliance. Schizophr Res 2004.
10 Beasley CM, Tollefson GD, Tran P. Safety of olanzapine. J Clin Psychiatry 1997.
11 Theisen FM, Linden A, Konig IR, Martin M, Remschmidt H, Hebebrand J. Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine. J Neural Transm 2003.
12 Wetterling T, Mubigbrodt HE. Weight gain: side effect of atypical neuroleptics. J Clin Psycopharmacology 1999.
13 Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatrica Scand 1999.
14 Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, et al. Novel Antipsychotics: Comparison of Weight Gain Liabilities. J Clin Psychiatry 1999.
15 Bernstein JG. Management of psychotropic drug-induced obesity. In: Bjorntorp P, Brodoff BN, eds. Obesity. Philadelphia, PA: J.B. Lippincott 1992.
16 Kelly DL, Conley RR, Love RC, Horn DS, Ushchak CM. Weight gain in adolescents treated with risperidone and conventional antipsycotics over six months. J Child Adolesc Psycopharmacol 1998.
17 Kinon BJ, Basson B, Szynanski KA, Tollefson G. Factors associated with weight gain during olanzapine treatment. Poster Session No. 10 presented at the 38 Annual Meeting for NCDEU (New Clinical Drug Evaluation Unit Program) 1998.
18 Lohr JB, Flynn K. Smoking and schizophrenia. Schizophr Res 1992.
19 Bjorntorp P. Endocrine abnormalities of obesity. Metabolism 1995.